The Role of the Parent Compound Vitamin D with Respect to Metabolism and Function: Why Clinical Dose Intervals Can Affect Clinical Outcomes
Top Cited Papers
Open Access
- 1 December 2013
- journal article
- review article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 98 (12), 4619-4628
- https://doi.org/10.1210/jc.2013-2653
Abstract
Context: There is no doubt that vitamin D must be activated to the hormonal form 1,25-dihydroxyvitamin D to achieve full biological activity or that many tissues participate in this activation process—be it endocrine or autocrine. We believe that not only is 25-hydroxyvitamin D important to tissue delivery for this activation process, but also that intact vitamin D has a pivotal role in this process. Objective: In this review, evidence on the vitamin D endocrine/autocrine system is presented and discussed in relation to vitamin D-binding protein affinity, circulating half-lives, and enzymatic transformations of vitamin D metabolites, and how these affect biological action in any given tissue. Conclusions: Circulating vitamin D, the parent compound, likely plays an important physiological role with respect to the vitamin D endocrine/autocrine system, as a substrate in many tissues, not originally thought to be important. Based on emerging data from the laboratory, clinical trials, and data on circulating 25-hydroxyvitamin D amassed during many decades, it is likely that for the optimal functioning of these systems, significant vitamin D should be available on a daily basis to ensure stable circulating concentrations, implying that variation in vitamin D dosing schedules could have profound effects on the outcomes of clinical trials because of the short circulating half-life of intact vitamin D.Keywords
This publication has 105 references indexed in Scilit:
- Effect of Vitamin D Supplementation on Blood Pressure in BlacksHypertension, 2013
- Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’BMC Infectious Diseases, 2013
- Vitamin D3supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention studyBMJ Open, 2012
- A Pooled Analysis of Vitamin D Dose Requirements for Fracture PreventionThe New England Journal of Medicine, 2012
- Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trialThe Lancet, 2012
- Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectivenessJournal of Bone and Mineral Research, 2011
- The Vitamin D Connection to Pediatric Infections and Immune FunctionPediatric Research, 2009
- Administration of oral vitamin D induces cathelicidin production in atopic individualsJournal of Allergy and Clinical Immunology, 2008
- Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerThe New England Journal of Medicine, 2006
- Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trialBMJ, 2003